Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Wilson Insider Profile
11 Followers
Martin Wilson, General Counsel at Teligent, holds 5.00K shares in Teligent (Ticker: TLGTQ), holds 63.56K shares in Rocket Pharmaceuticals (Ticker: RCKT). Most recently, Martin Wilson ― shares of Teligent on ― for an estimated value of ―.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+33.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
GC
Roles that Martin Wilson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Wilson
Martin Wilson's Trading History
Teligent
―
―
―
$50.00
Rocket Pharmaceuticals
Nov 25, 2024
GC
Informative Sell
15.33K
$734.75K
List of latest transactions for each holding click on a transaction to see Martin Wilson's performance on stock
You May Also Like
Martin Wilson insider profile FAQ
What is the percentage of profitable transactions made by Martin Wilson?
The percentage of profitable transactions made by Martin Wilson is 100%.
What is the average return per transaction made by Martin Wilson?
The average return per transaction made by Martin Wilson is 33.10%.
What stocks does Martin Wilson hold?
Martin Wilson holds: TLGTQ, RCKT stocks.
What was Martin Wilson’s latest transaction?
Martin Wilson latest transaction was an Uninformative Buy of ―.
What was Martin Wilson's most profitable transaction?
Martin Wilson’s most profitable transaction was an Informative Sell of RCKT stock on March 4, 2024. The return on the trade was 51.60%.
What is Martin Wilson's role in Teligent?
Martin Wilson's role in Teligent is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.